Biovie Ownership
| BIVI Stock | USD 2.80 0.09 3.32% |
Shares in Circulation | First Issued 2012-09-30 | Previous Quarter 6.2 M | Current Value 6.4 M | Avarage Shares Outstanding 7.1 M | Quarterly Volatility 9.6 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Biovie |
Biovie Stock Ownership Analysis
About 14.0% of the company shares are held by company insiders. The book value of Biovie was currently reported as 2.51. The company recorded a loss per share of 5.08. Biovie Inc last dividend was issued on the 22nd of November 2019. The entity had 1:10 split on the 6th of August 2024. BioVie Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of chronic debilitating conditions in the United States. BioVie Inc. was incorporated in 2013 and is headquartered in Carson City, Nevada. BioVie operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 13 people. For more info on Biovie Inc please contact Cuong MBA at 775 888 3162 or go to https://bioviepharma.com.Besides selling stocks to institutional investors, Biovie also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Biovie's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Biovie's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Biovie Quarterly Liabilities And Stockholders Equity |
|
Biovie Insider Trades History
About 14.0% of Biovie Inc are currently held by insiders. Unlike Biovie's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Biovie's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Biovie's insider trades
Biovie Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Biovie is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Biovie Inc backward and forwards among themselves. Biovie's institutional investor refers to the entity that pools money to purchase Biovie's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | New York State Common Retirement Fund | 2024-06-30 | 35.0 | Harbour Investments, Inc. | 2024-09-30 | 30.0 | Jaffetilchin Investment Partners, Llc | 2024-09-30 | 21.0 | Citigroup Inc | 2024-09-30 | 4.0 | Sanctuary Wealth Management, Llc | 2024-09-30 | 1.0 | Envestnet Asset Management Inc | 2024-09-30 | 0.0 | Spire Wealth Management | 2024-09-30 | 0.0 | Citadel Advisors Llc | 2024-06-30 | 0.0 | Millennium Management Llc | 2024-06-30 | 0.0 | Vanguard Group Inc | 2024-09-30 | 56.8 K | Geode Capital Management, Llc | 2024-09-30 | 38.2 K |
Biovie Inc Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Biovie insiders, such as employees or executives, is commonly permitted as long as it does not rely on Biovie's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Biovie insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Biovie Outstanding Bonds
Biovie issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Biovie Inc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Biovie bonds can be classified according to their maturity, which is the date when Biovie Inc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View |
Biovie Corporate Filings
| 27th of November 2024 Other Reports | ViewVerify | |
| 22nd of November 2024 Other Reports | ViewVerify | |
S1 | 21st of November 2024 Report filed by companies planning on going public to register their securities with the U.S. Securities and Exchange Commission (SEC) | ViewVerify |
10Q | 13th of November 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
Currently Active Assets on Macroaxis
When determining whether Biovie Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biovie's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biovie Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biovie Inc Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biovie Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biovie. If investors know Biovie will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biovie listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.08) | Return On Assets (0.67) | Return On Equity (2.08) |
The market value of Biovie Inc is measured differently than its book value, which is the value of Biovie that is recorded on the company's balance sheet. Investors also form their own opinion of Biovie's value that differs from its market value or its book value, called intrinsic value, which is Biovie's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biovie's market value can be influenced by many factors that don't directly affect Biovie's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biovie's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biovie is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biovie's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.